The groundbreaking rise of Viagra has long been a benchmark of pharmaceutical success, but its legacy within the broader industry now presents questions about long-term gains. Generic versions are eroding https://e-bookmarks.com/story7241621/the-blue-diamond-and-the-pharmaceutical-industry-a-risky-opportunity